AKAO Market Cap History
Below is a table of the AKAO market cap history going back to 3/12/2014:

Date AKAO Market Cap
3/12/2014225.66M
5/6/2014230.03M
8/6/2014163.29M
10/31/2014188.59M
3/2/2015195.08M
5/1/2015101.26M
8/5/2015130.61M
11/3/2015106.65M
3/4/201669.35M
4/29/201662.41M
8/2/201696.85M
11/2/2016115.02M
3/1/2017851.96M
5/3/2017880.92M
8/2/2017767.80M
11/2/2017551.12M
2/23/2018491.53M
5/2/2018658.51M
8/1/2018312.40M
11/1/2018181.25M
3/25/201933.22M

Also see: AKAO Shares Outstanding History
and AKAO YTD Return
AKAO Historical Market Cap:
-31.63% CAGR
AKAO Historical Market Cap: +-31.63% CAGR

Mouse over chart for data details
3/12/2014 ...3/25/2019
Achaogen is a biopharmaceutical company engaged in discovering, developing, and commercializing antibacterial treatments against multi-drug resistant (MDR) gram-negative infections. Co. develops plazomicin for the treatment of serious bacterial infections, including complicated urinary tract infection (cUTI), blood stream infections and other infections due to MDR Enterobacteriaceae, including carbapenem-resistant Enterobacteriaceae. Co. also develops antibacterial candidate, C-Scape, an orally-administered combination of ceftibuten and clavulanate for oral treatment for patients with cUTI, and acute pyelonephritis, caused by expanded spectrum beta-lactamases-producing Enterobacteriaceae. We show 21 historical shares outstanding datapoints in our AKAO shares outstanding history coverage, used to compute AKAO market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing AKAO market cap history over the course of time is important for investors interested in comparing AKAO's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of AKAO versus a peer is one thing; comparing AKAO market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like AKAO can fluctuate over the course of history. With this page we aim to empower investors researching AKAO by allowing them to research the AKAO market cap history.
Quotes delayed 20 minutes
Get Free SEC filing alerts for AKAO:
AKAO SEC Filing Email Alerts ServiceExternal link
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Achaogen (AKAO) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

AKBA Market Cap History
AKCA Market Cap History
AKER Market Cap History
AKRX Market Cap History
ALBO Market Cap History
ALC Market Cap History
ALDR Market Cap History
ALDX Market Cap History
ALGN Market Cap History
ALIM Market Cap History
More Healthcare companies »

 

AKAO Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2021, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.